Ketamine is easier to prescribe than ever, and the FDA is not happy about it
This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every
Read MoreThis article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every
Read MoreMIT Technology Review Explains: Let our writers untangle the complex, messy world of technology to help you understand what’s coming
Read MoreWASHINGTON US health authorities approved a new drug Friday to combat overdose deaths amid a persistent “major public health” crisis
Read MorePfizer is among several drugmakers racing to develop the world's first shot targeting Group B strep disease, which kills thousands
Read MoreAnalysts believe the Medicare registry requirement and new guidance on Leqembi's prescription label could potentially weigh on sales in the
Read MoreDrug slows cognitive decline by about 27% over 18 months, says Food and Drug Administration Source link
Read MoreThis article is from The Spark, MIT Technology Review’s weekly climate newsletter. To receive it in your inbox every Wednesday,
Read MoreFor now, Eli Lilly's orforglipron appears to be the top contender in the weight loss pill space due to its
Read MoreThe FDA's strain selection puts Pfizer, Moderna and Novavax on track to deliver updated coronavirus shots in time for the
Read More